Riskpilot← Back to searchSign inGet full accessKA Medica AB
ABActiveOrg 5592656259Södra Lillåstrand 26General medical practice activities · NACE 8621Est. 20201 employees
Revenue 2024
SEK 322K
+974% vs 2023
EBITDA margin
51.3%
+2781% vs 2023
Equity ratio
73.6%
Financial strength
Net profit 2024
SEK 131K
+2727% vs 2023
| Revenue | SEK 322K | +974% |
| EBITDA | SEK 165K | +2781% |
| Net profit | SEK 131K | +2727% |
| Total assets | SEK 351K | +150% |
| Equity | SEK 258K | +103% |
| Employees | 1 | — |
Legal name
KA Medica AB
Org number
5592656259
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 augusti 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsulttjänster åt primärvårdsmottagningar.
Address
Södra Lillåstrand 26
Email
khalid1371@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 177 | 129 | 30 | 322 |
| Staff expenses | — | −0 | −1 | −0 |
| EBITDA | 41 | 86 | 6 | 165 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 41 | 86 | 6 | 165 |
| Net financials | — | −2 | 0 | −0 |
| Profit before tax | 41 | 84 | 6 | 165 |
| Tax | −9 | −18 | −1 | −34 |
| Net profit | 32 | 66 | 5 | 131 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 122 | 205 | 141 | 351 |
| Equity | 57 | 123 | 127 | 258 |
| Long-term debt | 0 | 0 | 0 | — |
| Short-term debt | 65 | 82 | 13 | 93 |
| Total debt | 65 | 82 | 13 | 93 |
EBITDA margin
51.3%
This company
15.8%
Market median
+225% vs market
20212024
Equity ratio
73.6%
This company
38.2%
Market median
+93% vs market
20212024
Return on equity
50.7%
This company
18.4%
Market median
+176% vs market
20212024
Net profit margin
40.7%
This company
8.1%
Market median
+402% vs market
20212024
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
20212024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (5) | ||
| Deputy Board Member | 2020 – 2020 | |
| Deputy Board Member | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2020 | |
| Board of Directors | 2020 – 2020 | |
| Deputy Board Member | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KA Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Rick Stone Bjers | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Max Abbasi | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Khalid Abbasi | Board of Directors | 0 companies |